Arcus Biosciences RCUS Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcus Biosciences's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcus Biosciences's software and technology licenses, net?
- Arcus Biosciences (RCUS) reported software and technology licenses, net of $61M in Q1 2026.
- How has Arcus Biosciences's software and technology licenses, net changed year-over-year?
- Arcus Biosciences's software and technology licenses, net decreased by 14.1% year-over-year, from $71M to $61M.
- What is the long-term trend for Arcus Biosciences's software and technology licenses, net?
- Over 5 years (2020 to 2025), Arcus Biosciences's software and technology licenses, net has grown at a 58.8% compound annual growth rate (CAGR), from $6.25M to $63M.